← Back to Clinical Trials
Recruiting NCT07348523

NCT07348523 Comparison of the Postoperative Analgesic Efficacy of Classical and Modified Erector Spinae Plane Blocks After Lumbar Spinal Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07348523
Status Recruiting
Phase
Sponsor Samsun University
Condition Acute Pain
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-12-02
Primary Completion 2026-08-30

Trial Parameters

Condition Acute Pain
Sponsor Samsun University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age 70 Years
Start Date 2025-12-02
Completion 2026-08-30
Interventions
The Classical Erector Spinae Plane BlockModified Erector Spinae Plane Blocks

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The investigators aim to compare the postoperative analgesic efficacy of the classical erector spinae plane block and the modified erector spinae plane block in the management of postoperative analgesia after lumbar disc surgery.

Eligibility Criteria

Inclusion Criteria: * Patients aged 18-70 years, * Classified as ASA physical status I-III, * Scheduled to undergo single-level lumbar spinal surgery under general anesthesia * Who agree to participate in the study by providing written informed consent Exclusion Criteria: * History of bleeding diathesis or current anticoagulant therapy * Known allergy or hypersensitivity to local anesthetics or opioid medications * Infection at the planned block injection site * Previous lumbar spine surgery * History of gabapentinoid or corticosteroid use within the last 3 weeks * Inability to use a patient-controlled analgesia (PCA) device * Suspected pregnancy, confirmed pregnancy, or breastfeeding Refusal to undergo the procedure or to participate in the study

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology